Exelixis
EXEL
#1775
Rank
S$14.52 B
Marketcap
S$53.96
Share price
-1.34%
Change (1 day)
14.39%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: S$14.52 Billion

As of December 2025 Exelixis has a market cap of S$14.52 Billion. This makes Exelixis the world's 1775th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025S$14.52 B10.67%
2024S$13.12 B33.2%
2023S$9.85 B42.05%
2022S$6.93 B-11.29%
2021S$7.81 B-5.08%
2020S$8.23 B14.13%
2019S$7.21 B-10.43%
2018S$8.05 B-33.01%
2017S$12.02 B92.28%
2016S$6.25 B244.01%
2015S$1.81 B387.92%
2014S$0.37 B-73.99%
2013S$1.43 B39.6%
2012S$1.02 B23.5%
2011S$0.83 B-28.07%
2010S$1.15 B3.51%
2009S$1.11 B47.29%
2008S$0.75 B-41.72%
2007S$1.30 B-1.81%
2006S$1.32 B1.27%
2005S$1.30 B12.55%
2004S$1.16 B36.11%
2003S$0.85 B3.59%
2002S$0.82 B-52.28%
2001S$1.72 B45.84%
2000S$1.18 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Exelixis was reported to be:

S$14.66 Billion
by Nasdaq info icon info icon
S$14.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
S$126.08 B 768.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
S$152.99 B 953.29%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$319.36 B 2,098.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$134.87 B 828.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$221.95 B 1,428.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$640.22 B 4,307.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$189.76 B 1,206.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S$22.97 M-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S$0.67 B-95.34%๐Ÿ‡บ๐Ÿ‡ธ USA